Scientia Professor & Head of the School of Psychiatry, UNSW

Philip Mitchell AM, MB BS (Hons I), MD, FRANZCP, FRCPsych is Scientia Professor and Head of the School of Psychiatry at the University of New South Wales in Sydney, Australia; Member, Australian National Health and Medical Research Council (NHMRC) Research Committee; Councillor, CINP (Collegium Internationale Neuro-Psychopharmacologicum); Consultant Psychiatrist, Prince of Wales Hospital, Sydney; Director, Bipolar Disorders Clinic, Black Dog Institute, Sydney; Member of the NHMRC Assigners Academy; Guest Professor, Shanghai Jiaotong University; Visiting Professor, Harbin Medical University, China; Board Member of the Black Dog Institute; and Board Member of the Anika Foundation for Adolescent Depression and Suicide, Sydney.

His research and clinical interests are in bipolar disorder and depression, with a particular focus on: predictors of the development of bipolar disorder in at-risk individuals; molecular genetics of bipolar disorder; pharmacological and psychological treatments for bipolar disorder and depression; clinical phenomenology of bipolar disorder and depression; and stimulatory therapies for depression (such as transcranial magnetic stimulation and direct current stimulation).

Professor Mitchell has published (in conjunction with colleagues) over 385 peer-reviewed papers or book chapters on these topics and is lead investigator on an Australian NHMRC-funded Program Grant on depression and bipolar disorder. He is an associate editor of ‘Therapeutic Advances in Chronic Disease’ and ‘Neuropsychiatry’, and also serves on the editorial boards of ‘Psychiatric Genetics’, ‘CNS Drugs’, ‘CNS Spectrums’, ‘Current Therapeutic Research’, ‘Therapeutic Advances in Psychopharmacology’ and ‘Medicine Today’.